INDSWIFT LABORATORIES
Back to Balance Sheet
|
INDSWIFT LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-45 Cr | ₹-32 Cr | ₹-30 Cr | ₹-52 Cr | ₹-60 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of INDSWIFT LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-45 Cr |
| Mar2024 | ₹-32 Cr |
| Mar2023 | ₹-30 Cr |
| Mar2022 | ₹-52 Cr |
| Mar2021 | ₹-60 Cr |
How is Deferred Tax Assets / Liabilities of INDSWIFT LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-45 Cr | Negative | |
| Mar2024 | ₹-32 Cr | Negative | |
| Mar2023 | ₹-30 Cr | Negative | |
| Mar2022 | ₹-52 Cr | Negative | |
| Mar2021 | ₹-60 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹1,196.5 Cr | 4.4% | -3% | 63.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹403,052.0 Cr | 0.3% | -3.7% | -4.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,336.0 Cr | 2.4% | 6.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,311.0 Cr | -0.8% | -1.5% | 25.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,264.0 Cr | 7.9% | 4.6% | 4.6% | Stock Analytics | |
| CIPLA | ₹105,484.0 Cr | 5.5% | 5.4% | -18.5% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | 4.4% |
-3% |
63.5% |
| SENSEX | -0.4% |
1.3% |
0.8% |
You may also like the below Video Courses